Marshall Wace, LLP Rockwell Medical, Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 333,595 shares of RMTI stock, worth $300,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
333,595
Previous 596,359
44.06%
Holding current value
$300,235
Previous $1.22 Million
69.08%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RMTI
# of Institutions
53Shares Held
7.01MCall Options Held
92.8KPut Options Held
14.9K-
Armistice Capital, LLC New York, NY2.37MShares$2.13 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.08 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$668,9300.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny453KShares$407,7000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA325KShares$292,0850.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $9.61M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...